Organoids Market

Increasing Demand for Gene Mutation and Cancer Research to Drive Market

Over the past decade, organoids are being increasingly used in a range of applications, including disease modeling, pathogenesis, drug screening, and regenerative medicine, and the trend is set to continue during the forecast period. Organoid technologies have witnessed considerable developments in recent years, and continue to pave the way for the development of in vitro physiologic systems that model the origin tissues with high degree of accuracy compared to conventional approaches. The increasing focus on research and development activities is expected to play a key role in the development of the global organoids market during the assessment period.

The capability of 3D-organoid cultures to mimic organ functionality to some degree is one of the key factors likely to establish organoids as an ideal model for applications such as stem cell research to precision medicine. Furthermore, the increasing adoption of the organoid technology for use in a range of applications, including genetic mutation, gene assessment, and tumor modelling is expected to accelerate the overall development of the global organoids market during the assessment period. The assessment of different diseases by leveraging the organoid technology is anticipated to remain one of the most prominent applications of organoids in the upcoming years.

At the back of these factors coupled with the consistent rise in the investment for research and development, the global orgnoids market is expected to cross the market value of US$ 12.8 Bn by the end of 2030.

Request a sample to get extensive insights into the Organoids Market

Increasing Demand for Tumor Modelling and Biobanking to Propel Market Growth

The consistent progress in the organoid technology has gradually paved the way for ‘tumouroids’ and patient-centric 3D cultures of cells that are isolated from tumor biopsies. Over the past few decades, tumouroid lines have been established from a plethora of cancer types such as liver, breast, prostate, brain, bladder, and more from metastasis as well as primary tumors. Due to consistent advancements, in the current scenario, tumouroid lines are increasingly being passed in vitro, which opens up new avenues for a range of downstream applications. Moreover, 3D-based cultures offer additional advantages over the conventional 2D cancer-derived cell lines. Moreover, research and development activities have indicated that tumouroid culturing is highly efficient in enabling the collection of various cancer subtypes from a large pool of patients. As organoids can be easily derived and expanded from single cancer cells, the adoption of organoids to mimic intratumour diversification in culture is on the rise– a factor that is projected to propel the global organoids market during the assessment period.

To understand how our report can bring difference to your business strategy, Ask for a brochure

New Discoveries Driven by Research & Development to Boost Prospects

Research and development activities are set to play a key role in the overall development of the global organoids market during the assessment period. In addition, increasing collaborations between researchers and medical experts are anticipated to accelerate the development of complex organoids. For instance, two recent discoveries are expected to boost the overall prospects of next-generation organoid development. The new research collaboration between a team of scientists from the Cincinnati Children’s and Japan was announced in August 2020. As per the research team, discoveries from the new research collaboration are likely to be one of the most critical aspects for the development of a new wave of complex organoids. Although the organoid technology has progressed at a consistent pace over the past few years, the application of the same continues to remain sluggish in the current scenario. However, increasing focus on the commercialization of organoids and consistent progress in genome editing techniques are expected to bolster the growth of the global organoids market during the assessment period.

Demand for Human and Animal Organoids on Rise amid COVID-19 Pandemic

The advent of the novel COVID-19 pandemic is anticipated to open up new opportunities for the players involved in the current organoids market landscape. While researchers continue to assess the biology of the novel coronavirus, human and animal organoids are gradually anticipated to prove their value as an experimental virology platform. Furthermore, several researchers from various regions of the world have turned toward organoid technologies to assess the tissue tropism of the novel SARS-COV-2 virus.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Organoids Market

Analysts’ Viewpoint

The global organoids market is projected to expand at a high CAGR during the assessment period. Increasing prevalence of several diseases, outbreak of the novel COVID-19 pandemic, and rising adoption of organoids for disease modelling, gene mutation, and tumor modelling, advancements in organoid technology, and research and development activities are some of the key factors that are likely to drive the global organoids market during the assessment period. Furthermore, the increasing adoption of organoids as an ideal tool for respiratory infections and diseases will bolster the growth of the global organoids market during the assessment period.